Invention Grant
- Patent Title: Normalized calibration of analyte concentration determinations
-
Application No.: US14774617Application Date: 2014-03-07
-
Publication No.: US09958410B2Publication Date: 2018-05-01
- Inventor: Huan-Ping Wu
- Applicant: Bayer HealthCare LLC
- Applicant Address: CH Basel
- Assignee: Ascensia Diabetes Care Holdings AG
- Current Assignee: Ascensia Diabetes Care Holdings AG
- Current Assignee Address: CH Basel
- Agency: Nixon Peabody LLP
- International Application: PCT/US2014/021870 WO 20140307
- International Announcement: WO2014/159077 WO 20141002
- Main IPC: G01N27/327
- IPC: G01N27/327 ; G06F19/12 ; G01N33/72

Abstract:
Biosensor system measurement devices used to determine the presence and/or concentration of an analyte in a sample include normalized calibration information relating output signal or signals the device generates in response to the analyte concentration of the sample to previously determined reference sample analyte concentrations. The measurement devices use this normalized calibration information to relate one or more output signals from an electrochemical or optical analysis of a sample to the presence and/or concentration of one or more analytes in the sample. The normalized calibration information includes a normalization relationship to normalize output signals measured by the measurement device of the biosensor system and at least one normalized reference correlation relating normalized output signals to reference sample analyte concentrations.
Public/Granted literature
- US20160018355A1 Normalized Calibration Of Analyte Concentration Determinations Public/Granted day:2016-01-21
Information query